Randomized, investigator-masked, controlled, multicenter clinical trial of 0.25% amorolfine hydrochloride cream in the treatment of tinea corporis and cruris and tinea pedis;

Double-blind randomized controlled clinical trial of butenafine hydrochloride 1% cream in the treatment of tinea corporis and cruris and tinea pedis;

Multicenter, double-blind, randomized controlled sdudy on sertaconazole 2% cream and miconazole 2% cream in the treatment of tinea pedis and tinea corporis and cruris;

Liranaftate Cream in the Treatment of Tinea Cruris and Tinea Corporis:A Randomized Double-bind Vehicle-controlled Clinical Trial;

Objective:To evaluate the efficacy and the safety of liranaftate 2% cream in the treatment of tinea manuum & pedis and tinea corporis & cruris compared with bifonazole 1% cream.

METHODS: Butenafine hydrochoride 1% solution was compared with bifonazole 1% solution and was applied once daily for 4 weeks in the treatment of interdigital tinea pedis and for 2 weeks in the treatment of tinea corporis & cruris, both treatment groups had 2 weeks of follow-up observation after the end of treatment.

Isolation of dermatophytes from toe webs in patients with tinea cruris;

Analysis of isolates from 136 patients with tinea cruris;

Objective:To investigate the efficacy and safety of butenafine hydrochloride 1% cream in the treatment of tinea pedis,tinea cruris and tinea corporis.

Preparation of a novel ketoconazole spraying membrane and its effect on eczema and tinea corporis in guinea pigs;

Tinea corporis around the anterior nares in a child after close contact with a pet rabbit:a case report;

A case of unrecognized tinea corporis on the left arm that misdiagnosed for 2 years